Fact-checked by Grok 2 weeks ago

Tetraplegia

Tetraplegia, also known as quadriplegia, is a severe form of resulting from damage to the cervical , affecting all four limbs, the trunk, and often pelvic organs, leading to loss of motor function, sensation, and other bodily controls below the level of injury. This condition typically arises from at vertebral levels C1 through T1, where the injury disrupts nerve signals between the and body, with higher-level injuries (closer to the skull) causing more extensive impairment, including potential . The primary causes of tetraplegia are traumatic, such as accidents, falls (especially in those over 65), , and sports or recreational injuries, while non-traumatic etiologies include degenerative conditions like , infections, tumors, or disk herniation. Globally, over 15 million people live with as of 2024, with injuries—which cause tetraplegia—accounting for approximately 50–60% of cases and disproportionately impacting males (about 78% of new cases since 2015). Risk factors include ages 16–30 or over 65, or substance use (in about 25% of traumatic cases), and underlying conditions like . Symptoms of tetraplegia vary by injury completeness and level but commonly include total or partial loss of voluntary movement and in the arms, hands, legs, and torso; impaired bowel and control; ; or neuropathic sensations; and, in high injuries, difficulty or speaking due to weakened and . Complications can encompass , pressure ulcers, , respiratory infections, cardiovascular issues, and secondary psychological effects like , with the first year post-injury carrying the highest mortality risk from such conditions. Treatment focuses on acute stabilization to prevent further damage, followed by multidisciplinary to maximize independence, including medications for and , surgical interventions like or stabilization, assistive devices (e.g., wheelchairs, ventilators), and therapies for physical, occupational, and psychological support. While no cure exists for the underlying nerve damage, ongoing research into regenerative therapies, such as stem cells and neural prosthetics, offers hope for improved outcomes.

Definition and Terminology

Definition and Scope

Tetraplegia, also known as quadriplegia, is defined as affecting all four limbs and the due to damage to the cervical spinal cord (neurological levels C1 through C8), resulting in partial or complete loss of motor and sensory function below the level of injury. This condition impairs voluntary movement and sensation in the arms, hands, legs, , and often pelvic organs, distinguishing it from other forms of by its comprehensive impact on the upper and lower body. The term "tetraplegia" derives from the Greek roots "tetra," meaning four, and "plegia," meaning stroke or , emphasizing the involvement of all four extremities. In clinical practice, the severity of tetraplegia varies based on the specific spinal cord level affected, with injuries at higher levels (C1-C4) often leading to profound impairments including respiratory compromise due to diaphragmatic involvement, while lower injuries (C5-C8) may preserve some arm and hand function, such as elbow flexion or finger grasp. These variations relate to the neurological levels of , where function diminishes progressively from the site of damage. Tetraplegia is differentiated from , which involves limited to the lower limbs and trunk resulting from injuries below T1, typically in the thoracic or regions, thereby sparing upper body . This distinction underscores tetraplegia's broader scope, encompassing both upper and lower body deficits and necessitating comprehensive management of associated dependencies.

Historical and Terminological Notes

The term "quadriplegia" was coined in as a medical descriptor for affecting both arms and legs, derived from the Latin "quadri-" meaning four and "-plegia" meaning or , marking a shift from earlier phrases like "cervical paraplegia" used in the to denote similar upper-body impairments from spinal damage. This hybrid reflected the evolving in during an era when injuries were increasingly documented, though systematic care for such conditions remained limited until the mid-20th century. The term gained widespread adoption in clinical contexts following , particularly through the pioneering efforts of Sir , who established the UK's first specialized spinal injuries unit at in 1944 and emphasized comprehensive rehabilitation in the post- era. By the late , "quadriplegia" faced criticism for its mixed linguistic roots and implication of four identical limbs, which inaccurately described human where upper and lower differ structurally. In response, the American Spinal Injury Association (ASIA) and the International Society (ISCoS) promoted "tetraplegia"—a purely term from "tetra-" meaning four and "-plegia"—to enhance terminological precision and align with the anatomical reality that affected limbs function as part of a tetrapod (four-limbed) structure. This preference aimed to reduce confusion in international and avoid the pejorative or imprecise connotations of "quadriplegia," such as equating human arms and legs. Key milestones in this terminological evolution include the 1992 revision of the International Standards for Neurological Classification of , where , with ISCoS endorsement, first recommended "tetraplegia" over "quadriplegia" for its anatomical and etymological superiority. This was further standardized in the 1997 publication of the International Standards for Neurological and Functional Classification of by Maynard et al., which formalized "tetraplegia" in global guidelines for assessing and reporting spinal cord impairments, influencing subsequent editions and modern usage. Today, while "quadriplegia" persists as a synonym especially in North American contexts, "tetraplegia" predominates in peer-reviewed literature to promote clarity and consistency.

Anatomy and Pathophysiology

Cervical Spinal Cord Anatomy

The cervical spinal cord consists of eight segments (C1-C8), corresponding to the seven (C1-C7) that form the skeletal framework of the . These vertebrae, including the unique atlas (C1) and (C2), encase the within the vertebral canal, providing protection while allowing flexibility for head and movement. The region features an enlargement of the to support the extensive innervation of the upper limbs. Gray matter in the cord is arranged in an H-shaped cross-section, with ventral horns housing alpha motor neurons for control, dorsal horns processing sensory input, and an intermediate zone for facilitating reflexes. Surrounding is divided into anterior, lateral, and posterior funiculi, containing myelinated axons that conduct impulses at high speeds for efficient signal relay. Each segment produces a pair of spinal nerves (C1-C8) via the convergence of (sensory) and ventral (motor) roots within the intervertebral foramina. The C1-C7 nerves exit superior to their respective vertebrae, while C8 emerges between C7 and T1, enabling precise branching to target tissues. These nerves define specific myotomes and dermatomes: for instance, the myotome governs deltoid and contraction for and elbow flexion, while its dermatome covers the lateral upper ; handles wrist extension and sensation along the thumb side of the ; C7 controls extension and middle finger sensation; and C8 manages finger flexion with pinky-side innervation. The anterior rami of C3-C5 form the , which innervates the for essential respiratory function, highlighting the cervical cord's critical role in vital processes. Major tracts in the cord include the , which descends from the after decussating in the medullary pyramids to mediate voluntary skilled movements of the upper body, synapsing in the ventral horn's laminae VII-IX. The anterolateral ascends contralateral to its origin, conveying pain and temperature sensations from the upper extremities after crossing in the anterior white commissure shortly after dorsal root entry. The cord integrates seamlessly with the at the , where descending pathways from higher centers coordinate with local circuits for stabilization and upper limb dexterity via the (C5-T1). In normal , descending signals propagate unidirectionally through tracts to excite ventral horn motor neurons, which relay impulses via peripheral nerves to effectors, while ascending sensory volleys travel through dorsal roots and tracts to thalamic relays for conscious perception, ensuring bidirectional brain-periphery communication.

Injury Mechanisms and Pathophysiology

The primary injury in tetraplegia occurs due to mechanical forces applied to the cervical spinal cord, resulting in immediate tissue disruption through mechanisms such as , laceration, or transection of axons and supporting structures. often arises from displaced vertebral elements or , leading to focal deformation of neural tissue, while laceration involves shearing by bone fragments or foreign objects, and transection severs continuity across the cord. These events directly impair neuronal integrity at the injury site, typically in the C1-C8 segments, initiating irreversible loss of function in motor, sensory, and autonomic pathways below the lesion. Secondary injury cascades commence within minutes of the primary insult and evolve over hours to months, exacerbating damage through interconnected biochemical processes. Ischemia results from vascular compression or thrombosis, reducing blood flow and causing hypoxic cell death in the penumbra surrounding the core lesion. Inflammation is triggered by the release of pro-inflammatory cytokines such as TNF-α and IL-1β from activated microglia and infiltrating neutrophils, peaking in the acute phase (first 24-72 hours) and persisting subacutely with macrophage involvement. Excitotoxicity stems from glutamate overload, activating NMDA receptors and causing excessive calcium influx that damages neurons and oligodendrocytes. Oxidative stress arises from reactive oxygen species generated by disrupted mitochondria and enzymatic pathways, leading to lipid peroxidation and protein oxidation. Apoptosis, mediated by caspase activation, contributes to delayed neuronal and glial loss, extending from days to weeks post-injury. The timeline delineates acute events (minutes to days: ischemia, excitotoxicity, initial edema), subacute progression (days to weeks: peak inflammation, apoptosis), and chronic remodeling (months: ongoing oxidative damage and scar maturation). Pathophysiological outcomes include , where distal axons and myelin sheaths disintegrate due to disconnection from their cell bodies, becoming visible on MRI as hyperintense signals in tracts like the corticospinal and dorsal columns within 10-14 weeks. This process begins histologically within 8 days, leading to tract and functional deficits correlated with impaired evoked potentials. develops as a fluid-filled () within the cord, driven by subarachnoid scarring that alters dynamics, allowing influx into perivascular spaces and coalescence, with symptoms often emerging months to years post-injury (mean 9-15 years to diagnosis). In adults, is constrained by a hostile microenvironment featuring inhibitory molecules like proteoglycans and Nogo-A, barriers, and reduced regenerative factor expression, limiting axonal sprouting and circuit remodeling compared to developing nervous systems.

Etiology

Traumatic Causes

Traumatic causes account for the majority of tetraplegia cases, with approximately 60% of traumatic injuries (tSCI) occurring at the level, leading to tetraplegia. , the primary etiologies include collisions, which comprise about 38% of tSCI cases since 2015, often involving high-speed impacts that target the through mechanisms like whiplash-induced hyperextension or hyperflexion. Falls represent around 32% of cases, frequently resulting from household accidents or elevated drops that cause axial loading on the . Sports and recreational activities contribute to roughly 8% of tSCI, with accidents being a notable example where head-first entry into shallow water leads to forceful axial of the . , accounting for about 15% of cases, typically involve penetrating injuries such as or stab wounds to the , disrupting the directly. These etiologies often result in through biomechanical forces including hyperflexion (forward bending beyond normal limits), hyperextension (rearward bending), axial loading (vertical ), or rotational , which fracture or dislocate and compress or transect the cord. Age-specific risks highlight varying patterns: motor vehicle collisions and sports injuries predominate in young adults aged 16-30, driven by higher exposure to high-risk activities, while falls are the leading cause in individuals over 65, often due to reduced balance and osteoporosis increasing vertebral fragility. Overall, traumatic tetraplegia disproportionately affects males, comprising 78% of new cases since 2015.

Non-Traumatic Causes

Non-traumatic causes of tetraplegia encompass a range of endogenous medical conditions that damage or compress the cervical , distinct from external mechanical forces. Non-traumatic causes account for a significant and variable proportion of cases, estimated at 20-50% globally depending on region and income level, with higher rates in high-income countries; traumatic injuries comprise the majority in low- and middle-income countries. Unlike traumatic injuries, non-traumatic tetraplegia often presents with subacute or progressive onset, though acute presentations occur in vascular or infectious cases, and degenerative causes predominate in older adults. Neoplastic conditions, including intramedullary and extramedullary tumors, represent 15-30% of non-traumatic spinal cord injuries in various studies. These tumors, such as ependymomas, astrocytomas, or metastatic lesions, typically cause progressive compression of the , resulting in gradual motor and sensory deficits over weeks to months. Spinal metastases, often from primary cancers like or , are a common subtype in this category. Infectious etiologies, such as epidural abscesses or , contribute to acute or subacute tetraplegia through or direct cord invasion. These conditions often arise from bacterial, viral, or parasitic sources and can lead to rapid neurological deterioration if untreated, though they account for a smaller proportion compared to neoplastic or degenerative causes in high-income settings. Degenerative disorders, particularly spondylosis, are a leading cause, accounting for 20-50% of non-traumatic cases depending on the region and study, with higher proportions (up to 54%) in high-income countries and especially prevalent among individuals over 60 years old. This condition involves age-related wear on the spine, leading to , disc herniation, or formation that progressively compresses the , often manifesting as insidious weakness and in all four limbs. Vascular events, including spinal cord infarcts or arteriovenous malformations (AVMs), cause acute tetraplegia through ischemia or hemorrhage, typically in middle-aged or older adults with risk factors like or . These represent a significant but variable proportion of cases, emphasizing the role of disrupted blood supply in cord dysfunction. Inflammatory and autoimmune diseases, such as (MS) or Guillain-Barré syndrome (GBS), can result in tetraplegia via demyelination or immune-mediated attack on the . MS often leads to progressive or relapsing-remitting patterns affecting the cervical region, while GBS presents acutely with ascending paralysis that may involve the upper limbs; these etiologies highlight immune dysregulation as a key mechanism.

Clinical Features

Motor and Sensory Impairments

Tetraplegia, resulting from damage to the cervical , leads to significant motor and sensory deficits that impair function in the , , legs, and pelvic organs below the level of . These impairments arise from disruption of descending motor pathways, such as the corticospinal tracts, and ascending sensory pathways in the . In complete injuries, there is total loss of voluntary and sensation below the lesion, while incomplete injuries may preserve partial function. Motor impairments in tetraplegia initially manifest as during the acute phase of , characterized by areflexia and due to temporary loss of descending inhibitory influences on spinal reflexes. This phase typically resolves within days to weeks, giving way to , where and exaggerated reflexes emerge from unopposed spinal reflex activity. The specific motor deficits vary by the neurological level of , determined by the most caudal segment with intact innervation:
  • C1-C3 injuries: Complete paralysis of all four limbs and trunk, with no diaphragmatic function (phrenic nerve at C3-C5), necessitating permanent mechanical ventilation; patients retain only head and neck movement.
  • C4 injuries: Partial shoulder elevation and diaphragmatic breathing possible, but no arm or hand function, leading to total dependence for mobility.
  • C5 injuries: Preservation of shoulder abduction and elbow flexion (biceps), allowing limited arm positioning but no wrist or hand control.
  • C6 injuries: Addition of wrist extension, enabling tenodesis grasp for basic hand function, such as holding objects.
  • C7-C8 injuries: Elbow extension (triceps at C7) and finger flexion/extension (C8), permitting improved grasp and some independence in activities like self-feeding.
These level-specific losses are assessed using manual muscle testing on a 0-5 for key myotomes in the region. Sensory impairments involve complete or partial loss of below level, including (absence of feeling) and (tingling or abnormal sensations). Fine touch, vibration, and are primarily affected by damage to the dorsal columns, while crude touch, pain, and temperature are disrupted via the anterolateral spinothalamic tracts. The sensory level is defined as the most caudal dermatome with bilaterally. Basic evaluation follows the American Spinal Injury Association () standards, scoring light touch and pinprick sensation on a 0-2 (0 = absent, 1 = impaired, 2 = ) across 28 dermatomes from to S4-5 per side, with a maximum score of 112 for each modality. Functionally, these motor and sensory deficits result in high dependence for (ADLs), such as feeding, grooming, dressing, and wheelchair transfers, with the degree of assistance required increasing in higher lesions (C1-C4). For instance, individuals with C5-C6 injuries may achieve partial in upper body care using adaptive , but remains limited without powered s.

Autonomic and Other Symptoms

Autonomic dysfunction is a hallmark of tetraplegia due to disruption of supraspinal control over the , leading to sympathetic blunting and parasympathetic dominance below the level of injury. This manifests prominently in cardiovascular instability, such as , where systolic drops by at least 20 mmHg upon postural change, affecting up to 74% of individuals with tetraplegia and exacerbating risks during transitions. Temperature dysregulation is also common, with impaired sweating and causing or , particularly in high lesions where thermoregulatory efferents are compromised. Neurogenic bowel and bladder dysfunction further complicates daily management, resulting in incontinence, , or retention due to of voluntary control and detrusor-sphincter . is prevalent, with approximately 75% of men experiencing erectile issues and 95% facing ejaculatory difficulties, while women report reduced lubrication and sensation from disrupted reflex arcs. In high cervical tetraplegia, respiratory autonomic issues arise from involvement, causing diaphragm weakness, , and reliance on accessory muscles or ventilatory support. Beyond autonomic effects, other symptoms include , which affects 65-85% of individuals and presents as burning or shooting sensations from central or peripheral below the injury level. emerges post-acutely, characterized by velocity-dependent and spasms in about 65% of cases, often requiring pharmacological or physical interventions to mitigate interference with function. is a pervasive issue, linked to , pain, and sleep disturbances, impacting daily activities and quality of life. The initial phase, lasting days to weeks, features flaccid , areflexia, and absent , marking a transient loss of spinal excitability before reflex recovery. Psychosocial symptoms, such as and anxiety, occur in 30-50% of individuals with tetraplegia, influenced by the abrupt life changes and chronic symptom burden, though these require targeted support.

Diagnosis and Classification

Diagnostic Approaches

of tetraplegia begins with a thorough clinical to assess neurological and localize the injury level in the cervical spinal cord. In the acute setting, providers perform an initial evaluation of sensory , motor capabilities, and reflexes, guided by symptoms such as limb weakness or , while immobilizing the patient to prevent further damage. A comprehensive neurological follows, typically after 72 hours post-injury once has begun to resolve, using the International Standards for Neurological Classification of (ISNCSCI), which incorporates the American Spinal Injury Association () Impairment Scale. This scale grades injury severity from A (complete, no sensory or motor below the neurological level) to E (normal), based on bilateral testing of light touch and pinprick sensation across 28 dermatomes (scored 0-2 each) and manual muscle testing in 10 key myotomes (scored 0-5 each), helping to map sensory and motor levels. Reflex testing complements this by evaluating or absent responses in the lower limbs, which may indicate involvement during or after the phase. Imaging modalities are essential for visualizing structural damage and confirming the . Magnetic resonance imaging (MRI) is the preferred method for soft tissue evaluation, providing detailed views of , hemorrhage, , or contusion in the region, with high sensitivity for non-bony pathologies. Computed (CT) scans excel at detecting bony fractures, dislocations, or instability in the vertebrae, often using thin slices (≤3 mm for ) to assess injury extent with near-100% sensitivity for fractures. Plain X-rays serve as an initial screening tool to evaluate spinal alignment and gross vertebral damage, though they have lower sensitivity for subtle injuries and are typically supplemented by advanced imaging. Electrophysiological tests provide objective data on nerve conduction when clinical exams are inconclusive, such as in sedated or uncooperative patients. (EMG) assesses muscle electrical activity to differentiate from peripheral nerve involvement, while somatosensory evoked potentials (SSEPs) measure signal transmission from peripheral nerves to the , aiding in localization of conduction blocks in the cervical cord. Differential diagnosis involves excluding conditions mimicking tetraplegia, such as or , through integrated clinical history, imaging, and targeted testing; for instance, brain imaging rules out cerebral lesions, while nerve conduction studies distinguish central from peripheral etiologies.

Lesion Classification

Lesion classification in tetraplegia standardizes the assessment of cervical spinal cord injuries to determine the neurological level of injury (NLI), completeness, and functional impairments, aiding in and planning. The International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI), developed by the American Spinal Injury Association () and the International Spinal Cord Society (ISCoS), provides the primary framework through a standardized that evaluates sensory and motor functions across dermatomes and myotomes. The ISNCSCI worksheet determines the sensory level as the most caudal dermatome with normal sensation (light touch and pinprick scores of 2 bilaterally) and the motor level as the lowest key myotome with at least antigravity strength (grade ≥3/5), provided rostral levels are intact (grade 5/5). The neurological level of injury (NLI) is then defined as the most caudal segment where both sensory and motor functions are normal on both sides. For tetraplegia, classification focuses on cervical levels C1–C8, where injuries disrupt innervation to the upper and lower extremities, trunk, and potentially respiratory muscles. Higher lesions (C1–C4) often lack dedicated key myotomes in the ISNCSCI but are assessed via overall function, such as diaphragm integrity at C3–C5; lower lesions (C5–C8) correspond to specific upper limb functions.
Cervical LevelKey MyotomesPrimary Functions Affected
C1–C4None specified (neck flexors/extensors for C1–C3; via for C4)Head/neck control; (C4 primarily)
C5Elbow flexors (); deltoidShoulder abduction; elbow flexion
C6Wrist extensors (extensor carpi radialis)Wrist extension
C7Elbow extensors ()Elbow extension; wrist flexion
C8 flexors (flexor digitorum profundus to )Finger flexion
This table illustrates representative key muscle groups for C5–C8 as per ISNCSCI standards, with higher levels inferred from ancillary functions; for example, a motor level preserves , while C7 enables for extension. also distinguishes complete from incomplete lesions based on sacral sparing (S4–S5 segments). A complete shows no sensory or motor in S4–S5, including absent voluntary anal contraction, deep anal pressure, and sensory scores of 0 for light touch and pinprick. Incomplete lesions exhibit partial sacral sparing, indicating some preserved pathways. The ASIA Impairment Scale (AIS) further grades severity: Grade A (complete, no sacral sparing); Grade B (incomplete, sensory but no motor more than three levels below the motor level); Grade C (incomplete, motor preserved but fewer than half of key muscles below the NLI have strength ≥3/5); Grade D (incomplete, at least half of key muscles below the NLI ≥3/5); and Grade E (normal). For complete injuries, the zone of partial preservation (ZPP) identifies the caudal extent of partial innervation below the NLI. The AIS evolved from the earlier Frankel scale, which categorized injuries as A (complete), B (sensory preserved but motor useless), C (motor power preserved but not useful), D (useful motor function), or E (recovery), but the ISNCSCI provides more precise, quantifiable criteria for modern use. These systems ensure consistent categorization, particularly for tetraplegic lesions where C1–C8 involvement dictates the extent of quadriplegia and associated deficits.

Management

Acute Care

Upon arrival at a medical facility, for tetraplegia prioritizes stabilization of the airway, , and circulation (ABCs) to address immediate life-threatening issues, followed by spinal using a rigid and backboard to prevent secondary injury from movement. This initial resuscitation follows protocols, ensuring hemodynamic stability before transport to a specialized . High-dose administration remains controversial despite early evidence from the National Acute Spinal Cord Injury Studies (NASCIS II and III), which suggested modest neurological benefits when initiated within 8 hours of injury via a 24-hour regimen. Subsequent analyses and guidelines, including those from the American Association of Neurological Surgeons (AANS) and Congress of Neurological Surgeons (CNS), highlight risks such as increased , , and mortality, leading to recommendations against routine use except in select cases where benefits may outweigh harms. (MAP) is targeted at 85 mmHg or higher for the first 7 days post-injury to optimize , using vasopressors like norepinephrine if needed, though recent guidelines suggest a lower threshold of 75-80 mmHg with an upper limit of 90-95 mmHg to avoid complications; a 2025 randomized trial found no significant neurological benefits from targeting MAP >85-90 mmHg compared to >65-70 mmHg for 7 days, but noted increased adverse events with higher targets, further supporting cautious lower thresholds. Surgical intervention focuses on decompression of the , ideally within 24 hours of , as supported by the Surgical Timing in Acute Study (STASCIS), which demonstrated improved neurological outcomes (at least a 2-grade improvement on the American Spinal Injury Association Impairment Scale) compared to later . For unstable cervical injuries common in tetraplegia, stabilization via or is performed concurrently to maintain alignment and prevent further cord compression. Early (within 24-48 hours) is associated with reduced secondary and better functional recovery, particularly in incomplete injuries. In the (ICU), patients with high cervical lesions (C1-C4) often require due to diaphragmatic and intercostal muscle , with tracheostomy considered for prolonged support beyond 7-10 days to facilitate and reduce complications. Thromboembolism prophylaxis is initiated within 72 hours using (LMWH) or unfractionated once is achieved, as acute tetraplegia confers a high of deep vein thrombosis and without increasing bleeding significantly. Mechanical methods like are used adjunctively in the interim.

Long-Term Rehabilitation

Long-term rehabilitation for tetraplegia adopts a multidisciplinary designed to optimize functional independence, prevent secondary complications, and enhance after the acute phase of management. This process addresses persistent motor and sensory impairments by emphasizing restorative strategies that promote and adaptive compensation. Coordinated by a physiatrist, the team integrates input from physical therapists, occupational therapists, nurses, psychologists, speech-language pathologists, and social workers to tailor interventions to individual needs. Rehabilitation unfolds in distinct phases, beginning with inpatient care lasting 6-12 weeks in specialized units, where the focus shifts to intensive mobility training, (ADLs), and foundational skills like transfers and propulsion. Passive and active-assisted range-of-motion exercises, along with positioning techniques, are prioritized to mitigate contractures and maintain integrity during this period. Transitioning to outpatient and community-based , which may extend 3-12 months or longer with annual follow-ups, emphasizes skill refinement, home modifications, and sustained participation in societal roles. Physical and occupational therapies form the cornerstone, with physical therapy targeting strengthening of preserved muscles, , and through exercises like resistance (8-12 repetitions, 2-3 days per week) and (FES) cycling to reduce . Occupational therapy concentrates on upper extremity function and ADLs, incorporating adaptive techniques for dressing, feeding, and hygiene. Speech therapy supports respiratory management in tetraplegia, using techniques such as manually assisted coughing and exercises to improve capacity and secretion clearance. Assistive technologies are essential for , including power wheelchairs equipped with hand joysticks for C5-C8 levels or alternative controls like chin or for higher injuries, alongside FES devices for hand grasp facilitation and basic exoskeletons for supported standing and gait training. Nurses contribute through vigilant skin care protocols, such as regular repositioning and pressure-relief education, to avert ulcers, while psychologists provide coping mechanisms, cognitive-behavioral therapy, and support for adjustment to . Goals are customized by injury level to leverage remaining function; for instance, C5 tetraplegia prioritizes tenodesis grasp training, involving extension exercises to passively flex fingers for pinching and holding objects like utensils, thereby enabling semi-independent and tasks. Overall, these strategies foster long-term outcomes like community reintegration, with evidence indicating improved independence through consistent, goal-oriented programming.

Prognosis and Complications

Prognostic Factors

The prognosis for individuals with tetraplegia, a form of () affecting the region, is influenced primarily by the injury's level and completeness, as determined by the American Spinal Injury Association (ASIA) Impairment Scale (AIS). High-level complete injuries (AIS A) at C1-C3 carry a particularly poor outlook, with first-year survival rates of approximately 80-90% under modern intensive care due to and dependence, improved from historical rates below 50%. In contrast, incomplete injuries (AIS B-D) at any level offer substantially better prospects, with 50-80% of patients improving by at least one AIS grade within the first year, often regaining some motor or sensory function below the injury site. Age at injury and the timing of surgical intervention also play critical roles in predicting functional recovery. Patients under 50 years of age demonstrate superior outcomes, such as an 80-90% rate of walking recovery in motor-incomplete (AIS C) tetraplegia, compared to 30-40% for those 50 or older, due to greater and fewer comorbidities. Early decompressive within 24 hours of more than doubles the likelihood of achieving at least a two-grade improvement in AIS score at six months ( 2.76), facilitating better neurological preservation through reduced secondary ischemia. Motor recovery in tetraplegia typically follows a defined timeline, with the most substantial gains occurring in the first 6-12 months post-injury, after which progress plateaus around 12-18 months. For incomplete tetraplegia, approximately 75% of AIS C patients achieve ambulatory status by one year, though this drops to about 20-25% in cases with very low initial lower extremity motor scores (1-9 points). Upper limb motor recovery is more consistent, with 90% of incomplete cases regaining some function, emphasizing the importance of early rehabilitation during this peak window. Long-term survival and life expectancy in tetraplegia vary by injury characteristics but are generally reduced compared to the general population, particularly for high-level lesions. For low-level incomplete injuries (e.g., C5-C8, AIS B-D), life expectancy approaches 80-90% of age-matched norms, with 40-year survival rates exceeding 60% among first-year survivors. However, respiratory complications, such as pneumonia, significantly diminish longevity in high tetraplegia, where ventilator dependence can halve expected lifespan regardless of completeness.

Associated Complications

Individuals with tetraplegia face a range of secondary health complications due to immobility, neurogenic dysfunction, and impaired physiological regulation (based on studies from 2010-2024). Pressure ulcers, also known as pressure injuries, affect 20-50% of individuals with , often developing within the first few years post-injury due to prolonged pressure on over bony prominences. Urinary tract infections (UTIs) are highly prevalent, occurring in 10-68% of cases, primarily from neurogenic leading to urinary and catheterization-related risks. Respiratory complications, such as , are particularly common in tetraplegia, with incidence rates of 40-70% in acute phases, exacerbated by reduced diaphragmatic function and ineffective cough mechanisms. develops rapidly, impacting over 50% within the first year and more than 80% long-term, resulting from disuse and hormonal imbalances below the injury level. , often neuropathic in nature, affects 34-90% of those with , manifesting as burning or aching sensations at or below the lesion site. Autonomic dysreflexia, a potentially life-threatening triggered by noxious stimuli below the injury level, occurs in 48-90% of individuals with lesions at or above T6, leading to symptoms like severe , sweating, and . Prevention strategies include regular skin inspections, repositioning every 2 hours (turning schedules) to mitigate pressure ulcers, and clean intermittent catheterization or suprapubic tubes to reduce UTI risk. For , bisphosphonates such as alendronate are used to inhibit , alongside weight-bearing exercises when feasible. Respiratory support involves assisted ventilation, , and vigilant monitoring to prevent . These complications contribute significantly to mortality, with from sources like UTIs, pressure ulcers, and accounting for 15-20% of deaths in chronic populations. Late-onset issues include post-traumatic , characterized by formation within the , detected in 21-30% of cases on from 1 to 30 years post-injury, with symptomatic cases affecting 3-9% and potentially worsening neurological deficits. Heterotopic , the abnormal bone growth in soft tissues around joints, arises in 20-30% of spinal cord injury patients, commonly in the hips and knees, leading to joint stiffness and requiring early detection via for interventions like etidronate.

Epidemiology

Global Incidence and Prevalence

Tetraplegia, resulting from cervical (), accounts for approximately half of all new cases worldwide, with an estimated global incidence of 250,000–450,000 new cases annually as of (assuming ~50% of total incidence of 500,000–900,000), corresponding to an age-standardized incidence rate () of approximately 3–4 per 100,000 (or 30–40 per million). Traumatic causes such as falls and collisions account for the majority. The global of tetraplegia stood at 7.42 million people in , with an age-standardized rate (ASPR) of 88.47 per 100,000 (or 885 per million). This equates to nearly half of the total 14.5–20.6 million individuals living with globally, reflecting the severity and longevity of cervical-level impairments. Regional variations show higher ASPR in high sociodemographic index (SDI) regions, such as high-income (139 per 100,000) and (225 per 100,000), attributed to improved survival rates and aging populations, while lower rates prevail in (49 per 100,000). In low- and middle-income countries, crude may be elevated due to higher burdens, though underreporting affects estimates. Trends indicate a stable to slightly increasing absolute burden of tetraplegia, driven by population growth and aging, though age-standardized rates have declined slightly due to epidemiological improvements. Non-traumatic causes, including degenerative diseases, are rising in aging populations, contributing to overall prevalence. Emerging data from the period (2020–2022) suggest a relative increase in non-traumatic proportions in certain settings, potentially linked to delayed healthcare access, though global traumatic incidence declined during lockdowns. Projections to 2050 estimate continued absolute growth to approximately 7.3 million cases, despite declining age-standardized rates.

Demographic Patterns

Tetraplegia displays a bimodal age distribution, reflecting differences between traumatic and degenerative etiologies. Traumatic cases peak among young adults aged 15–30 years, where males constitute approximately 80% of affected individuals due to higher engagement in high-risk activities. In contrast, degenerative causes predominate in those over 65 years, often linked to age-related spinal conditions. The condition exhibits a pronounced sex disparity, with a male-to-female ratio of about 4:1. This imbalance stems primarily from males' greater involvement in occupational hazards, such as and , and contact sports like and , which elevate injury risks. Geographically, tetraplegia incidence is markedly higher in low- and middle-income countries (LMICs), estimated at 13–76 per million population in regions like compared to approximately 8–58 per million in . These variations arise from socioeconomic factors, including poorer , limited safety regulations, and inadequate in LMICs. Within LMICs, rural areas often report elevated rates relative to urban settings, driven by accidents and falls from heights in farming environments.

Research and Emerging Therapies

Current Research Areas

Current research in for tetraplegia, a form of (), emphasizes strategies to mitigate secondary injury cascades such as and ischemia. Clinical trials have explored agents like , which demonstrates neuroprotective effects through multiple mechanisms including inhibition of microglial activation and reduction of in animal models of . Similarly, of silymarin has shown evidence of , activity, and action in compression models, improving functional recovery in preclinical studies conducted between 2023 and 2025. (HGF) is another promising candidate, protecting fibers and reducing secondary damage in models. Ongoing trials, such as one evaluating glyburide's neuroprotective effects (NCT05426681), incorporate analyses in and to assess efficacy in mitigating secondary injury. However, a 2024 study indicated that prolonged use of common medications at standard doses did not significantly impact recovery post-, highlighting the need for targeted dosing in future investigations. Therapeutic hypothermia remains a focal point for neuroprotection, with recent trials demonstrating its potential to reduce secondary injury by lowering metabolic demand and inflammation. A 2025 systematic review and meta-analysis assessed the safety and efficacy of systemic hypothermia (33°C) in acute traumatic SCI, synthesizing evidence from human studies and reporting overall feasibility, potential neurological improvements, and low rates of major adverse events. Preclinical and early clinical data from 2023-2025 support hypothermia's role in preserving tissue integrity when initiated early after injury. Epidemiological studies on secondary injury have advanced biomarker identification to predict injury progression and enable early intervention. Between 2023 and 2025, research identified dynamic trajectories in routine blood tests—such as inflammatory markers and coagulation factors—as predictive biomarkers for SCI recovery, using machine learning on large datasets like MIMIC to forecast outcomes with high validity. Coagulation-related biomarkers, including D-dimer and fibrinogen, have been linked to SCI severity through bioinformatics analyses of patient cohorts, revealing immune-inflammatory pathways that exacerbate secondary damage. A 2025 transcriptional study established a comprehensive reference for SCI severity and progression, pinpointing novel genes like those involved in neuroinflammation as potential diagnostic tools from blood samples. In the realm of regeneration, animal models continue to elucidate mechanisms of regrowth following . Studies from 2024-2025 using and models have identified key genes and pathways promoting axonal sprouting, such as those modulated by semaphorin 3A inhibitors, which enhanced regeneration in chronic rat models when combined with other interventions. Single-cell RNA sequencing in regenerating spinal cords revealed innate immune cells and transcription factors driving successful regrowth, providing a blueprint for mammalian research. Bioinformatics analyses of datasets highlighted interplay between regeneration genes and immune infiltration, with hub genes like Mapk1 and Ptbp1 emerging as therapeutic targets. Human cohort studies have quantified natural recovery rates in incomplete tetraplegia, informing expectations for spontaneous neural . Longitudinal analyses from 2023-2025 indicate that approximately 20-30% of patients with incomplete achieve meaningful motor within the first year, driven by remyelination and circuit remodeling, based on data from large registries tracking over 1,000 cases. These cohorts, drawn from international databases, show that younger age and milder initial impairment correlate with higher rates, with approximately 70-90% regaining some ambulatory function in ASIA C injuries, particularly younger patients, through natural mechanisms and . Technological integration in tetraplegia research leverages wearables and for enhanced monitoring and outcome prediction. Wearable sensors, including inertial devices and multisensor activity monitors, have proven feasible for daily activity tracking in acute trials, with 2025 studies demonstrating high sensitivity in detecting subtle motor improvements in injury patients during inpatient rehabilitation. algorithms applied to wearable data predict energy expenditure and levels in users with , enabling personalized monitoring of secondary complications like pressure injuries. AI models have advanced prognostic accuracy, analyzing multimodal data to forecast trajectories. A 2025 AI framework using routine bloodwork identified patterns predicting survival and functional outcomes post-SCI with over 85% accuracy, outperforming traditional scales in cohort validations. applications from 2024-2025, including and neural networks, predict walking function and AIS grade improvements based on electrophysiological and clinical variables, achieving scores above 0.90 in benchmarked datasets. Longitudinal studies utilizing SCI registries like the Registry (RHSCIR) have integrated AI for real-time analysis of over 10,000 cases from 2024-2025, revealing temporal patterns in recovery and informing adaptive protocols.

Potential Future Treatments

Stem cell therapy, particularly using mesenchymal stem cells (MSCs), represents a promising avenue for restoring function in tetraplegia by promoting neural repair and reducing inflammation at the injury site. Phase II and III clinical trials have demonstrated modest improvements in motor function, particularly in patients with incomplete injuries, with some studies reporting gains in American Spinal Injury Association () scores of 2-4 levels in motor and sensory domains following autologous MSC transplantation. For instance, a 2025 systematic review and of human studies indicated that MSC therapies led to significant neurological improvements, such as enhanced and bowel function, in chronic cases, though efficacy remains limited in complete injuries. Neural interfaces are advancing rapidly to bypass damaged pathways in tetraplegia, enabling direct brain-to-device communication and motor control. Brain-computer interfaces (BCIs), inspired by technologies like , received FDA approval for human trials in May 2023, with the first implant in a quadriplegic patient in early 2024 allowing cursor control and communication via thought. By 2025, had implanted devices in additional patients, including one with enabling text-based communication, demonstrating sustained functionality for over a year in initial cases. Complementing BCIs, epidural electrical stimulation (EES) of the has shown potential for recovery; 2025 clinical studies reported improved overground walking and motor scores in incomplete tetraplegia patients when EES was combined with , with one case series noting voluntary leg movement in chronic injuries. Pharmacological interventions targeting and regeneration offer additional hope for tetraplegia treatment. , an FDA-approved drug for , has exhibited neuroprotective effects in acute through glutamate modulation; post-2023 analyses of the RISCIS phase III trial, including a 2025 reanalysis, revealed improved motor recovery and functional independence when administered within 12 hours of injury, particularly in cervical-level tetraplegia. Exosome-based therapies, derived from mesenchymal stem cells, are emerging for regeneration by delivering growth factors to promote regrowth and reduce secondary damage; preclinical and early 2025 studies in models demonstrated nerve rewiring and functional recovery, with phase I/II trials planned for 2026 showing promising safety profiles in acute cases. approaches for remyelination aim to restore of damaged s using vectors to express myelin-promoting genes; while still in preclinical stages as of 2025, recent reviews highlight their potential in combination with cell therapies, with initial human trials anticipated based on animal models achieving partial remyelination and motor gains in incomplete injuries.

References

  1. [1]
    Quadriplegia (Tetraplegia): Definition, Causes & Types
    Aug 10, 2022 · Quadriplegia is a symptom of paralysis that affects all a person's limbs and body from the neck down.
  2. [2]
    Spinal cord injury - Symptoms and causes - Mayo Clinic
    Aug 17, 2024 · A spinal cord injury often causes permanent changes in strength, feeling and other body functions below the site of the injury.
  3. [3]
    About Spinal Cord Injury | NICHD
    Jan 25, 2022 · Tetraplegia (formerly called quadriplegia) generally describes the condition of a person with an SCI that is at a level anywhere from the C1 ...
  4. [4]
    Spinal cord injury - World Health Organization (WHO)
    Apr 16, 2024 · Spinal cord injury (SCI) refers to damage to the spinal cord resulting from trauma (eg from falls and road traffic injuries) or non-traumatic causes.
  5. [5]
    Spinal Cord Injuries - StatPearls - NCBI Bookshelf - NIH
    Jun 2, 2025 · Spinal cord injury (SCI) is a neurologic condition resulting from trauma or nontraumatic etiologies that disrupt motor, sensory, and autonomic pathways.Spinal Cord Injuries · Pathophysiology · Treatment / Management
  6. [6]
    Spinal cord injury - Diagnosis and treatment - Mayo Clinic
    Aug 17, 2024 · Spinal cord injury treatment focuses on preventing further injury and empowering people to return to an active and productive life.
  7. [7]
    Spinal Cord Injury | National Institute of Neurological Disorders and ...
    Apr 7, 2025 · An injury to the upper part of the spinal cord can cause paralysis in most of the body and affect all limbs (tetraplegia or quadriplegia).
  8. [8]
  9. [9]
    tetraplegia, n. meanings, etymology and more
    OED's earliest evidence for tetraplegia is from 1911, in a translation by F. S. Arnold. tetraplegia is formed within English, by compounding. Etymons: tetra- ...<|control11|><|separator|>
  10. [10]
    Types & Levels of Spinal Injuries - Shepherd Center
    For example, a cervical injury may lead to tetraplegia (loss of function in all four limbs), while a lumbar injury may cause paraplegia (loss of function in the ...
  11. [11]
    Quadriplegia - Etymology, Origin & Meaning
    Originating in 1895 from Latin-based quadri- "four" + Greek -plegia "stroke," paralysis means loss of movement in both arms and legs.
  12. [12]
    Spinal Cord Injury—Past, Present, and Future - PMC - NIH
    This special report traces the path of spinal cord injury (SCI) from ancient times through the present and provides an optimistic overview of promising ...
  13. [13]
    Challenging questions regarding the international standards - PMC
    Aug 18, 2017 · Why was the term changed to “tetraplegia” from “quadriplegia”? The 1992 revision to the Standards were endorsed by the International Spinal Cord ...
  14. [14]
    Physiology, Spinal Cord - StatPearls - NCBI Bookshelf
    Mar 17, 2023 · Cervical nerves (C1-C8): the cervical spinal cord is enlarged because spinal nerves from this area go to the upper extremities, which have more ...
  15. [15]
    Topographic and Functional Anatomy of the Spinal Cord
    Mar 17, 2025 · C1-C7 nerves emerge above their respective vertebrae. C8 emerges between the seventh cervical and first thoracic vertebrae. The remaining nerves ...
  16. [16]
    Cervical Spine (Neck): What It Is, Anatomy & Disorders
    Jan 18, 2022 · They're labeled C1 through C8. They stimulate muscle movement in your neck, shoulder, arm and hand, and provide sensation.
  17. [17]
    Neuroanatomy, Spinal Nerves - StatPearls - NCBI Bookshelf
    Aug 14, 2023 · More specifically, there are eight cervical nerve pairs (C1-C8), twelve thoracic nerve pairs (T1-T12), five lumbar nerve pairs (L1-L5), 5 ...
  18. [18]
    Anatomy of the Spine and Peripheral Nervous System - AANS
    Eight pairs of cervical nerves exit the cervical cord at each vertebral level. One member of the pair exits on the right side and the other exits on the left.
  19. [19]
  20. [20]
    Wallerian degeneration in cervical spinal cord tracts is commonly ...
    Oct 30, 2020 · Wallerian degeneration is commonly seen in routine MRI after traumatic spinal cord injury. Wallerian degeneration is visible in the anatomical regions.
  21. [21]
    Post-Traumatic Syringomyelia | PM&R KnowledgeNow
    Jun 19, 2024 · Syringomyelia is the development of a longitudinal fluid-filled cyst, also referred to as a syrinx, within the grey matter of the spinal cord.
  22. [22]
    Spinal cord injury: molecular mechanisms and therapeutic ... - Nature
    Jun 26, 2023 · The challenges of SCI repair include its complex pathological mechanisms and the difficulties of neural regeneration in the central nervous system.
  23. [23]
    [PDF] Traumatic Spinal Cord Injury Facts and Figures at a Glance - MSKTC
    The most recent estimate of the annual incidence of traumatic spinal cord injury (tSCI) is approximately 54 cases per one million people in the United States, ...
  24. [24]
    Cervical Injury - StatPearls - NCBI Bookshelf - NIH
    Jun 2, 2025 · These injuries can result from a variety of mechanisms, including motor vehicle collisions, falls, sports-related impacts, and other forms of ...Cervical Injury · History And Physical · Evaluation
  25. [25]
    Epidemiology and contemporary risk profile of traumatic spinal cord ...
    Nov 2, 2015 · Sports and leisure and transport-related injuries were the predominant causes of TSCI in the youngest age group (aged 16 to 30); falls were the ...
  26. [26]
    Nontraumatic spinal cord injury: incidence, epidemiology ... - PubMed
    Results: Of SCI admissions, 39% were nontraumatic in etiology (spinal stenosis, 54%; tumor, 26%). Compared to subjects with traumatic SCI, those individuals ...Missing: percentages | Show results with:percentages
  27. [27]
    Clinical Presentation and Causes of Non-traumatic Spinal Cord Injury
    Aug 8, 2021 · Results: Of ninety-three included cases, thirty-six (38.7%) were diagnosed with NTSCI. Fifty-two patients (55.9%) were classified as MMs. In ...
  28. [28]
    Epidemiology of Spinal Cord Injury: Changes to Its Cause Amid ...
    Falls was the single most common cause of traumatic SCI, and tripping over was the most common cause of injury in the elderly patients. OPLL was prevalent in ...
  29. [29]
    Spinal Cord Injury From Spinal Tumors: Prevalence, Management ...
    It has been reported that tumor-associated compression causes 10% of new-onset SCIs and ≤26% of nontraumatic SCIs.3 These patients have high healthcare expenses ...
  30. [30]
    Clinical Presentation and Causes of Non-traumatic Spinal Cord Injury
    Aug 9, 2021 · Etiologies include degenerative, inflammatory, neoplastic and infectious conditions (1, 4–6). To prevent long-term disability and death, early ...
  31. [31]
    Traumatic and non-traumatic spinal cord injury - PubMed Central - NIH
    In our cohort, 67% of the injured patients were male; this percentage was higher in T-SCI group (male 81%, female 19%). Non-traumatic patients were ...
  32. [32]
    Nontraumatic Spinal Cord Injury: Epidemiology, Etiology and ...
    The prevalence is around 2% and is caused by spinal cord compression due to degenerative changes in the spinal column components [10].
  33. [33]
    Traumatic vs. Non-Traumatic Spinal Cord Injury—Epidemiology ...
    However, according to Guan et al., the number of new cases of SCIs has been decreasing over the last 30 years in eastern and central European countries [22].
  34. [34]
    Autonomic Dysfunction and Management after Spinal Cord Injury
    Jul 7, 2022 · After a spinal cord injury (SCI), supraspinal influence on the ANS is disrupted, leading to sympathetic blunting and parasympathetic dominance.
  35. [35]
    Vascular dysfunctions following spinal cord injury - PMC
    Autonomic dysreflexia appears during the chronic phase, after spinal shock resolution, and it is a life–threatening syndrome of massive imbalanced reflex ...
  36. [36]
    Thermodysregulation in persons with spinal cord injury: case series ...
    Dec 6, 2017 · Thermoregulatory dysfunction is a well-known consequence of SCI and has been shown to negatively impact comfort and the ability to perform vital ...
  37. [37]
    Neurogenic bladder in spinal cord injury patients - PMC - NIH
    Neurogenic bladder dysfunction due to spinal cord injury poses a significant threat to the well-being of patients. Incontinence, renal impairment, urinary tract ...
  38. [38]
    Sexuality, Intimacy, and Reproductive Health after Spinal Cord Injury
    Dec 1, 2022 · A large percentage of men with SCI suffer from erectile dysfunction (75%) [11], ejaculatory problems (95%) [12], and poor semen quality, ...
  39. [39]
    Respiratory problems and management in people with spinal cord ...
    Respiratory impairment following spinal cord injury (SCI) is more severe in high cervical injuries, and is characterised by low lung volumes and a weak ...
  40. [40]
    Prevalence and Characteristics of Neuropathic Pain in Patients With ...
    Chronic pain is a common secondary complication in patients with spinal cord injury (SCI), and between 65% and 85% of patients with SCI have reported pain ...
  41. [41]
    a systematic review of spasticity outcomes in acute spinal cord injury ...
    Feb 17, 2022 · Spasticity is a common consequence of spinal cord injury (SCI) and is estimated to affect around 65% of patients with SCI discharged from acute ...
  42. [42]
    Spinal Shock - StatPearls - NCBI Bookshelf
    Feb 12, 2024 · Spinal shock is the sudden, temporary loss or impairment of spinal cord function below the level of injury that occurs after an acute spinal cord injury.
  43. [43]
    Spinal cord injury and mental health - PubMed
    Results: Nearly half (48.5%) of the population with spinal cord injury suffered mental health problems of depression (37%), anxiety (30%), clinical-level stress ...Missing: tetraplegia | Show results with:tetraplegia
  44. [44]
  45. [45]
    Diagnosis and Prognosis of Traumatic Spinal Cord Injury - PMC
    A relatively new approach for evaluating the extent of the spinal cord damage is the assessment of biomarker concentrations in the cerebrospinal fluid.Diagnosis · The Neurological Examination · Diagnostic Imaging
  46. [46]
    How is SCI diagnosed? | NICHD
    Jan 25, 2022 · Doctors use the standard ASIA (American Spinal Injury Association) Impairment Scale for this diagnosis. X-rays, MRIs, or more advanced imaging ...
  47. [47]
    [PDF] ASIA-ISCOS-IntlWorksheet_2019.pdf
    CLASSIFICATION OF SPINAL CORD INJURY. (ISNCSCI). Page 2. Page 2/2. A = Complete. No sensory or motor function is preserved in the sacral segments S4-5. B ...
  48. [48]
    International Standards for Neurological Classification of Spinal ...
    Definitions. Tetraplegia (preferred to “quadriplegia”): This term refers to impairment or loss of motor and/or sensory function in the cervical segments of the ...
  49. [49]
    [PDF] BEST PRACTICES GUIDELINES SPINE INJURY
    This Best Practices Guideline (BPG) begins with the epidemiology of spinal injury, then reviews pre-hospital spinal motion restriction, cervical collar ...
  50. [50]
    [PDF] Early Acute Management in Adults with Spinal Cord Injury: - PVA.org
    Admit patients with complete tetraplegia and injury level at C5 or rostral to an intensive care unit. ... Categorization and Standards of Care: Spinal Cord Injury ...
  51. [51]
    Methylprednisolone for acute spinal cord injury: not a standard of care
    A high-dose, 24-hour infusion of methylprednisolone started within 8 hours after an acute closed spinal cord injury is not a standard treatment nor a guideline ...
  52. [52]
    A Clinical Practice Guideline for the Management of Patients With ...
    Mar 25, 2024 · The GDG suggested that MAP should be augmented to at least 75-80 mmHg as the “lower limit,” but not actively augmented beyond an “upper limit” ...
  53. [53]
    results of the Surgical Timing in Acute Spinal Cord Injury ... - PubMed
    Conclusion: Decompression prior to 24 hours after SCI can be performed safely and is associated with improved neurologic outcome, defined as at least a 2 grade ...
  54. [54]
    Results of the Surgical Timing in Acute Spinal Cord Injury Study ...
    STASCIS represents the largest prospective multi-center study comparing early vs. late surgical decompression in the setting of acute traumatic spinal cord ...
  55. [55]
    Respiratory problems and management in people with spinal cord ...
    High-level tetraplegic patients may be safely managed without invasive ventilation or tracheostomy in units with significant SCI and NIV expertise [114]. Whilst ...
  56. [56]
    Venous Thromboembolism Following Spinal Cord Injury - PMC - NIH
    A systematic review of the treatment of venous thromboembolism in SCI patients has provided reasonably good evidence supporting pharmacological prophylaxis.
  57. [57]
    Rehabilitation of spinal cord injuries - PMC - NIH
    Tetraplegia (preferred to “quadriplegia”)​​ This term refers to impairment or loss of motor and/or sensory function in the cervical segments of the spinal cord ...Introduction · Tetraplegia (preferred To... · Tetraparesis And Paraparesis<|control11|><|separator|>
  58. [58]
    Physiotherapy management of people with spinal cord injuries
    This topical review focuses on physiotherapy interventions for the management of people with SCI. It summarises the burden and classification of SCI.Invited Topical Review · Burden Of Spinal Cord Injury · Physiotherapy Management Of...
  59. [59]
    Evidence based clinical practice guideline for follow-up care in ...
    Sep 8, 2024 · Initially, after primary rehabilitation, persons should attend follow-up appointments at 3, 6, and 12 months. Subsequently, annual appointments ...<|control11|><|separator|>
  60. [60]
    Physiotherapy Management of Individuals with Spinal Cord Injury
    A functional, goal-oriented, interdisciplinary, rehabilitation programme should enable the individual with a spinal cord injury to live as full and independent ...
  61. [61]
    [PDF] SPINAL CORD INJURY GUIDELINES 2021
    Feb 2, 2021 · 1. Paralysis of the lower limbs in patients with a spinal cord injury (SCI) and paraplegia or tetraplegia shifts dependence for mobility to the ...
  62. [62]
    A Clinical Practice Guideline for the Management of Patients With ...
    The objective of this study is to develop guidelines that outline the appropriate type and timing of rehabilitation in patients with acute spinal cord injury ( ...<|control11|><|separator|>
  63. [63]
    Life expectancy and long-term survival after traumatic spinal cord ...
    Key factors to survival rate are age, severity of lesion (complete versus incomplete), neurological level of injury (high versus low), and the need for chronic ...
  64. [64]
    Characterizing Natural Recovery after Traumatic Spinal Cord Injury
    The prognosis for AIS C recovery to AIS D is greater for patients with initial AIS C injuries than for those with initial motor complete lesions (AIS A and B).
  65. [65]
    Who is going to walk? A review of the factors influencing walking ...
    Mar 13, 2014 · For patients with incomplete paraplegia, lower extremity motor scores, pinprick scores and age were the best predictors for walking recovery.
  66. [66]
    Timing of Decompressive Surgery in Patients With Acute Spinal ...
    Mar 25, 2024 · Based on moderate evidence, patients were 2 times more likely to recover by ≥ 2 grades on the ASIA Impairment Score (AIS) at 6 months (RR: 2.76, ...
  67. [67]
    Prognosis and Goal Setting in Spinal Cord Injury - Physiopedia
    Total paralysis of the diaphragm and respiratory muscles occurs in those with a C1-C2 lesion, while those with a C3 lesion may retain some level of diaphragm ...
  68. [68]
    Life expectancy after spinal cord injury: a 50-year study - PubMed
    Among first-year survivors, overall 40-year survival rates were 47 and 62% for persons with tetraplegia and paraplegia, respectively.
  69. [69]
    Global, regional, and national burden of spinal cord lesion at neck ...
    Sep 5, 2025 · In 2021, global incidence was 306,568 (age-standardized incidence rate [ASIR] 3.78/100,000), prevalence 7.42 million (age-standardized ...
  70. [70]
    Spinal Cord Injury Epidemiology and Causes: A Worldwide Analysis ...
    Results: In 2021, approximately 14.5 million people worldwide were living with SCI, including 7.30 million with neck-level and 7.22 million with below-neck- ...
  71. [71]
    The Impact of COVID-19 on Epidemiological Features of Spinal ...
    This study aims to describe the epidemiological profile of SCI during the COVID-19 pandemic (“COVID-19 period”) and before and after the COVID-19 pandemic (“ ...<|separator|>
  72. [72]
    Epidemiology of worldwide spinal cord injury: a literature review | JN
    Dec 29, 2017 · Previous researches have shown that the age of SCI patients trends to be bimodal distribution, the first peak is 15–29 and the second is over 65 ...
  73. [73]
    The Impact of Age on Mortality, Impairment, and Disability among ...
    The age distribution of those with traumatic spinal cord injury (SCI) is characterized by a bimodal distribution, with a peak incidence among young adults ...
  74. [74]
    A demographic profile of new traumatic spinal cord injuries - PubMed
    The male/female ratio remained fairly stable at 4:1, but the percentage of women increased slightly over time, especially from MVC etiologies.
  75. [75]
    The prevalence and impact of age and gender on rehabilitation ...
    Feb 26, 2013 · Epidemiological studies of SCI have consistently shown a male predominance ranging from male to female ratio of 4:1 in the developed world to ...
  76. [76]
    Burden of Traumatic Spinal Cord Injury in Sub-Saharan Africa
    Aug 28, 2023 · The incidence of TSCI varied from 13 per million population per year in Botswana to 75.6 per million population per year in South Africa.
  77. [77]
    The demographics and traumatic causes of spinal cord injury in Nepal
    Jul 28, 2020 · Falls were the leading cause of TSCI across both genders and all age groups, followed by RTIs, which occurred most often in young adults and men.
  78. [78]
    Traumatic Spinal Cord Injury: Review of the Literature - MDPI
    Minocycline is a tetracycline antibiotic that has anti-inflammatory properties and shows promising neuroprotective capacity through multiple mechanisms.
  79. [79]
    evidence for neuroprotection, antioxidant, and anti-inflammatory action
    Intrathecal silymarin administration improves recovery after compression spinal cord injury: evidence for neuroprotection, antioxidant, and anti-inflammatory ...
  80. [80]
    Current and emergent therapies targeting spinal cord injury
    Research has shown that HGF is promising in the context of spinal cord injuries, as it has been found to protect the fibers of the corticospinal tract in ...
  81. [81]
    Next-gen spinal cord injury clinical trials - The Lancet
    Oct 8, 2024 · An ongoing trial investigating the neuroprotective effect of Glyburide (NCT05426681) has also incorporated serum and CSF biomarker analyses into ...
  82. [82]
    No impact of anti-inflammatory medication on inflammation-driven ...
    Our data indicate that the prolonged use of these anti-inflammatory agents at commonly used doses did not profoundly impact recovery following an SCI.
  83. [83]
    Safety and Efficacy of Therapeutic Hypothermia in Acute Traumatic ...
    Oct 28, 2025 · Background: Therapeutic hypothermia as a neuroprotective strategy can reduce secondary injury after acute traumatic spinal cord injury (SCI).Missing: 2023-2025 | Show results with:2023-2025
  84. [84]
    [PDF] Title Page Safety and Efficacy of Therapeutic Hypothermia in Acute ...
    Oct 28, 2025 · Therapeutic hypothermia as a neuroprotective strategy can reduce secondary injury after acute traumatic spinal cord injury (SCI). Although ...
  85. [85]
    Modeling trajectories of routine blood tests as dynamic biomarkers ...
    Jul 22, 2025 · We demonstrate that the dynamics of routinely collected blood tests hold prediction validity in acute Spinal Cord Injury (SCI). Using MIMIC data ...Missing: epidemiology | Show results with:epidemiology
  86. [86]
    Identification of coagulation diagnostic biomarkers related to the ...
    Aug 20, 2024 · This study aims to identify blood coagulation diagnostic biomarkers and immune changes related to SCI and its severity levels.
  87. [87]
    A comprehensive transcriptional reference for severity and ...
    Feb 4, 2025 · A comprehensive transcriptional reference for severity and progression in spinal cord injury reveals novel translational biomarker genes. Rubén ...
  88. [88]
    Chronic Spinal Cord Injury Regeneration with Combined Therapy ...
    Jan 23, 2024 · In this study of rats with SCI, we propose a novel combined therapy involving a semaphorin 3A inhibitor (Sema3Ai), which enhances axonal regeneration.
  89. [89]
    Single-cell analysis of innate spinal cord regeneration identifies ...
    Aug 15, 2024 · This study provides a comprehensive resource of the cells and mechanisms that direct spinal cord regeneration and establishes zebrafish as a model of ...
  90. [90]
    Interplay of axon regeneration genes and immune infiltration in ...
    Oct 1, 2025 · To investigate the relationships among axon regeneration genes in SCI, gene expression data were collected from three mouse SCI model datasets.
  91. [91]
    Feasibility and Sensitivity of Wearable Sensors for Daily Activity ...
    Jul 10, 2025 · Wearable inertial sensors collected data from 69 individuals with acute, traumatic cervical SCI participating in the Nogo-A Inhibition in Spinal ...
  92. [92]
    Using Machine Learning with Wearable Devices to Advance ...
    Oct 10, 2025 · Predicting energy expenditure of manual wheelchair users with spinal cord injury using a multisensor-based activity monitor. Arch Phys Med ...
  93. [93]
    AI breakthrough finds life-saving insights in everyday bloodwork
    Sep 23, 2025 · AI-powered analysis of routine blood tests can reveal hidden patterns that predict recovery and survival after spinal cord injuries.
  94. [94]
    A Benchmark of Predicting Walking Function after Spinal Cord Injury
    Oct 30, 2025 · In light of growing biomedical data, machine learning (ML) models offer tremendous potential for personalized prediction in medicine.
  95. [95]
    National SCI Registry: RHSCIR - Praxis Spinal Cord Institute
    RHSCIR enables provincial, national and international data exchange to advance SCI research and care through. Data is collected through its secure, shared ...A Vision To Improve Care · Connecting People From Coast... · Rhscir FacilitiesMissing: longitudinal | Show results with:longitudinal<|control11|><|separator|>
  96. [96]
    A Systematic Review and Meta-Analysis of Human Studies - PMC
    May 23, 2025 · A phase III clinical trial showing limited efficacy of autologous mesenchymal stem cell therapy for spinal cord injury. Neurosurgery. 2016 ...Missing: tetraplegia | Show results with:tetraplegia
  97. [97]
    (PDF) Stem Cell Therapy for Spinal Cord Injury: A Review of Recent ...
    Aug 6, 2025 · Results: In both cases, cell therapy achieved a clear improvement in neurological sequels, such as recovery of gait disturbances, bowel ...
  98. [98]
    Stem cell therapy for patients with paraplegia - Taylor & Francis Online
    Both groups showed significant improvements in total ASIA. (American Spinal. Cord Injury. Association) scores (2-4 level improvement in both motor and sensory ...
  99. [99]
    Neuralink Updates
    Neuralink is developing a fully-implanted, wireless, high-channel count, brain-computer interface (BCI) with the goal of enabling people with paralysis to ...Missing: tetraplegia | Show results with:tetraplegia
  100. [100]
    Neuralink brain implant allows ALS patient to communicate
    May 5, 2025 · The company announced in early 2024 that 29-year-old quadriplegic Noland Arbaugh became the first person to receive one of Neuralink's BCI ...
  101. [101]
    Neuralink's brain-computer interfaces: medical innovations and ...
    Mar 23, 2025 · In May 2023, Neuralink received FDA approval (after a rejection in 2022) for human clinical trials but the traditional process of scientific ...
  102. [102]
    Epidural Electrical Stimulation for Functional Recovery in Incomplete ...
    Jul 22, 2025 · This study confirms the promising therapeutic effects of EES in SCI. EES combined with PT provides a potential approach for functional recovery in patients ...
  103. [103]
    Spinal epidural electrical stimulation for the recovery of motor ...
    Jun 30, 2025 · Locomotor training with sEES improves the motor abilities and functional recovery of persons with chronic SCI. A larger prospective study is ...
  104. [104]
    results from the RISCIS randomised controlled trial analysed using a ...
    Jul 24, 2025 · The RISCIS Trial (Safety and Efficacy of Riluzole in Acute Spinal Cord Injury Study), reported in 2023, highlights the potential limitations of ...
  105. [105]
    Drug used for motor neuron diseases holds promise for spinal cord ...
    Sep 16, 2025 · "For the first time, we are able to show, supported by evidence, that a pharmacologic agent with a neuroprotective effect is able to treat ...
  106. [106]
    Regenerate, rewire, recover: Exosome-based therapy regenerates ...
    Aug 11, 2025 · These results suggest that silencing PTEN with ExoPTEN could be applied in places where damaged neurons need to regenerate, rewire and recover, ...
  107. [107]
    a promising cell-free approach for spinal cord injury
    Apr 17, 2025 · Exosomes promote SCI repair by enhancing nerve regeneration, reducing inflammation and stabilizing the blood-spinal cord barrier.
  108. [108]
    Spinal Cord Injury Remyelination: Pathways to Therapies - MDPI
    However, a 2024 review of pharmacologic therapies concluded that previously conducted clinical trials ... clinical trials of SCI therapies as of 6 June 2025 ...